ExactAntigen

glyceraldehyde 3 phosphate dehydrogenase antibody review
GAPDH antibodies
This is a review about glyceraldehyde 3 phosphate dehydrogenase antibodies, based on 31 published articles using glyceraldehyde 3 phosphate dehydrogenase antibodies in western blot, immunohistochemistry, immunoprecipitation, immunocytochemistry, and other immunological technologies. It is aimed to help ExactAntigen visitors find the most suited glyceraldehyde 3 phosphate dehydrogenase antibody. Information in this review (with links to publications) can be searched freely.
ChIP assay (chip), immunocytochemistry (ic), western blot (wb)
ABDSEROTEC    search AbDSerotec GAPDH products
includes other brands or spellings
wb    Biogenesis anti-GAPDH antibody was used in western blot to detect GAPDH in cytosolic extracts from HeLa cells untreated or incubated with cytochrome c and dATP in the presence or absence of NS3694, DEVD-CHO and zVAD-fmk as a load control.
wb    Biogenesis monoclonal anti–glyceraldehyde-3-phosphate dehydrogenase antibody 6G7 was used in western blot to study the role of the caspase-4 in endoplasmic reticulum stress-induced apoptosis and Aß-induced cell death.
SIGMA-ALDRICH    search Sigma-Aldrich GAPDH products
includes other brands or spellings
wb    Sigma Aldrich anti-GAPDH antibody was used in western blot to detect GAPDH as a protein loading control in cultured CD34+ cells isolated from blood samples of CHD patients.
SANTA CRUZ BIOTECHNOLOGY    search Santa Cruz Biotechnology GAPDH products
includes other brands or spellings
wb    Santa Cruz Biotechnology antibody for glyceroaldehyde-3-phosphate dehydrogenase (GAPDH) was used in western blot to study the importance of Ca2+–calmodulin-dependent myosin light chain kinase (MLCK) for activation of TRPC5 channels expressed in HEK293 cells.
wb    Santa Cruz Biotechnology glyceraldehyde-3-phosphate dehydrogenase antibody was used in western blot to study the role of Cyr61 in endometrial tumorigenesis.
wb    SCBT GAPDH antibody was used in western blot to investigate the induction of IL-8 by the Helicobacter pylori CagA protein.
NOVUS BIOLOGICALS    search Novus Biologicals GAPDH products
includes other brands or spellings
wb    Novus Biologicals rabbit polyclonal anti-glyceraldehyde-3-phosphate dehydrogenase antibody was used in parental A431 human vulvar epidermoid carcinoma cells and in western blot to study the function for Dsg1 in facilitating apoptotic elimination of damaged cells.
ABCAM    search Abcam GAPDH products
includes other brands or spellings
wb    Abcam mouse anti-glyceraldehyde-3-phosphate dehydrogenase monoclonal antibody was used in western blot to study that phosphorylation of claudin-3 at threonine 192 by cAMP-dependent protein kinase regulates tight junction carrier function in ovarian cancer cells.
wb    Abcam anti-GAPDH antibody was used in human aortic VSMCs and in western blot to study the effect of advanced glycation end products on chymase-dependent angiotensin II–generating pathway in diabetic complications.
MILLIPORE    search Millipore GAPDH products
includes other brands or spellings
chip, wb    Chemicon International mouse polyclonal anti-glyceraldehyde-3-phosphate dehydrogenase antibody was used in western blot to study the expression of translation elongation factor eEF1A2 in breast tumours.
ic, wb    Chemicon International mouse monoclonal antibodies anti-GAPDH were used in western blot and immunocytochemistry to study the inhibitory effect of small interfering RNA urokinase silencing on the invasion and migration of human hepatocellular carcinoma cells.
wb    Chemicon mouse anti-glyceraldehyde 3-phosphate dehydrogenase (GAPDH) antibody was used in western blot to study the expression of LPP.
wb    Chemicon International mouse anti-glyceraldehyde-3-phosphate dehydrogenase (GAPDH) monoclonal antibody was used in western blot to study the inhibitory effects of galanin receptor 1 on proliferation in oral squamous cell carcinoma.
wb    Chemicon International monoclonal anti-GAPDH antibody MAB374 was used in western blot to study the involvement of tumor necrosis factor receptor-associated protein 1 (TRAP1) in apoptosis which was induced by β-hydroxyisovalerylshikonin.
wb    Chemicon International anti-GAPDH (glyceraldehyde phosphate dehydrogenase) antibody was used in western blot to study the significance of the NEDD8 pathway for proteasome-mediated degradation of human estrogen receptor (ER) -alpha and for the antiproliferative activity of ICI 182, 780 in ER-positive breast cancer cells.
wb    Chemicon International anti-GAPDH antibody was used in western blot to study the alpha-synuclein degradation by serine protease neurosin.
wb    Chemicon mouse anti-GAPDH was used in western blot to detect the level of endogenous GAPDH expression in HEK cells.
wb    Chemicon mouse anti-human GAPDH antibody was used in western blot as a loading control in human placenta during normal gestation (6–40 weeks).
wb    Chemicon anti-GAPDH antibody was used in western blot to study ceruloplasmin expresion in the retina after photic injury.
TREVIGEN    search Trevigen GAPDH products
wb    Trevigen anti-GAPDH antibody was used in western blot to study that IFI16 is an essential mediator of growth inhibition, but not differentiation, induced by the leukemia inhibitory factor/JAK/STAT pathway in medullary thyroid carcinoma cells.
COVANCE    search Covance GAPDH products
includes other brands or spellings
wb    Covance GAPDH (glyceraldehyde-3-phosphate dehydrogenase) antibody was used in western blot to identify the homologues of the caenorhabditis elegans Fox-1 protein as neuronal splicing regulators in mammals.
wb    Babco GAPDH antibody was used in western blot to study the effect of human p53 serine 46 phosphorylation on promoter selection and apoptosis.
ADVANCED IMMUNOCHEMICAL
wb    Advanced ImmunoChemical mouse anti-GAPDH antibody was used in western blot to support a model where, in response to flow activation, the PI3K signal transduction pathway converges on histones surrounding the KLF2 promoter to alter chromatin structure through the PCAF acetyltransferase.
AMBION
wb    Ambion mouse monoclonal anti-GAPDH antibody was used in western blot to detect GAPDH in RAW 264.7 cells.
BIODESIGN
wb    Biodesign anti-glyceraldehyde-3-P dehydrogenase monoclonal antibody was used in western blot to detect GAPDH as a load control in 293T cells transfected with human TSC2 and TSC1.
HYTEST
wb    HyTest monoclonal glyceraldehyde-3-phosphate dehydrogenase antibody (clone 6C5) was used in western blot in CD34+ human progenitor cells, bone marrow cells, and tumor cells to ensure eaqual loading of the gel.
wb    HyTest glyceraldehyde-3-phosphate dehydrogenase antibody was used in western blot to study its activation by the NAD (P) H oxidase inhibitor 4- (2-aminoethyl) benzenesulfonyl fluoride.
RESEARCH DIAGNOSTIC
wb    Research Diagnostic GAPDH (TRK5G4-6C5) antibody was used in western blot to study the control mechanisms of HCFC1 transcriptional coactivator.
RESEARCH DIAGNOSTICS
wb    Research Diagnostics mouse monoclonal anti-GAPDH antibody was used in western blot to study the function of FAST as a survival protein with ability to sense mitochondrial stress and modulate TIA-1-regulated changes in protein expression.
wb    Research Diagnostics anti-GAPDH was used in western blot to study SP/NK1R-induced cell death mediated by a MAP kinase activation pathway involving Raf-1, MEK2, and extracellular signal-regulated protein kinase 2 (ERK2).
wb    Research Diagnostics antibody against Gapdh was used in western blot to investigate how hypoxia-induced growth arrest could be a signal for modification of p53 at serine 15, as well as the involvement of the ATM or ATR kinases in this modification.


Articles Reviewed
1. Ester M Hammond et al. Hypoxia links ATR and p53 through replication arrest. 2002
2. Meiyun Fan et al. The NEDD8 pathway is required for proteasome-mediated degradation of human estrogen receptor (ER)-alpha and essential for the antiproliferative activity of ICI 182,780 in ERalpha-positive breast cancer cells. 2003
3. Lin Chen et al. Increased expression of ceruloplasmin in the retina following photic injury. 2003
4. Isabelle Gorenne et al. LPP, a LIM protein highly expressed in smooth muscle. 2003
5. Ariel F Castro et al. Rheb binds tuberous sclerosis complex 2 (TSC2) and promotes S6 kinase activation in a rapamycin- and farnesylation-dependent manner. 2003
6. Atsushi Iwata et al. Alpha-synuclein degradation by serine protease neurosin: implication for pathogenesis of synucleinopathies. 2003
7. Gary Guishan Xiao et al. Use of proteomics to demonstrate a hierarchical oxidative stress response to diesel exhaust particle chemicals in a macrophage cell line. 2003
8. Ulrik Lademann et al. Diarylurea compounds inhibit caspase activation by preventing the formation of the active 700-kilodalton apoptosome complex. 2003
9. Susana Castro-Obregón et al. Alternative, nonapoptotic programmed cell death: mediation by arrestin 2, ERK2, and Nur77. 2004
10. Junichi Hitomi et al. Involvement of caspase-4 in endoplasmic reticulum stress-induced apoptosis and Abeta-induced cell death. 2004
11. Kerstin Schag et al. Identification of C-met oncogene as a broadly expressed tumor-associated antigen recognized by cytotoxic T-lymphocytes. 2004
12. Bharat Khurana et al. A protein sequestering system reveals control of cellular programs by the transcriptional coactivator HCF-1. 2004
13. Alessandro Salvi et al. Small interfering RNA urokinase silencing inhibits invasion and migration of human hepatocellular carcinoma cells. 2004
14. Saranya Kittanakom et al. Trafficking defects of a novel autosomal recessive distal renal tubular acidosis mutant (S773P) of the human kidney anion exchanger (kAE1). 2004
15. Yutaka Masuda et al. Involvement of tumor necrosis factor receptor-associated protein 1 (TRAP1) in apoptosis induced by beta-hydroxyisovalerylshikonin. 2004
16. Wenwen Chien et al. Cyr61 suppresses growth of human endometrial cancer cells. 2004
17. Eun-Joo Kim et al. IFI16 is an essential mediator of growth inhibition, but not differentiation, induced by the leukemia inhibitory factor/JAK/STAT pathway in medullary thyroid carcinoma cells. 2005
18. Wei Li et al. FAST is a survival protein that senses mitochondrial stress and modulates TIA-1-regulated changes in protein expression. 2004
19. Shigeru Akagi et al. The critical role of SRC homology domain 2-containing tyrosine phosphatase-1 in recombinant human erythropoietin hyporesponsive anemia in chronic hemodialysis patients. 2004
20. Bradley S Henson et al. Galanin receptor 1 has anti-proliferative effects in oral squamous cell carcinoma. 2005
21. Nastiti Wijayanti et al. Heme oxygenase-1 gene activation by the NAD(P)H oxidase inhibitor 4-(2-aminoethyl) benzenesulfonyl fluoride via a protein kinase B, p38-dependent signaling pathway in monocytes. 2005
22. Justin P Huddleson et al. Induction of KLF2 by fluid shear stress requires a novel promoter element activated by a phosphatidylinositol 3-kinase-dependent chromatin-remodeling pathway. 2005
23. Lindsey D Mayo et al. Phosphorylation of human p53 at serine 46 determines promoter selection and whether apoptosis is attenuated or amplified. 2005
24. Rachana Agarwal et al. Phosphorylation of claudin-3 at threonine 192 by cAMP-dependent protein kinase regulates tight junction barrier function in ovarian cancer cells. 2005
25. Sabine Brandt et al. NF-kappaB activation and potentiation of proinflammatory responses by the Helicobacter pylori CagA protein. 2005
26. Victoria A L Tomlinson et al. Translation elongation factor eEF1A2 is a potential oncoprotein that is overexpressed in two-thirds of breast tumours. 2005
27. Jason G Underwood et al. Homologues of the Caenorhabditis elegans Fox-1 protein are neuronal splicing regulators in mammals. 2005
28. Shunichi Shimizu et al. Ca2+-calmodulin-dependent myosin light chain kinase is essential for activation of TRPC5 channels expressed in HEK293 cells. 2006
29. Rachel L Dusek et al. The differentiation-dependent desmosomal cadherin desmoglein 1 is a novel caspase-3 target that regulates apoptosis in keratinocytes. 2006
30. Vijay Koka et al. Advanced glycation end products activate a chymase-dependent angiotensin II-generating pathway in diabetic complications. 2006
31. Alexandra Gellhaus et al. Decreased expression of the angiogenic regulators CYR61 (CCN1) and NOV (CCN3) in human placenta is associated with pre-eclampsia. 2006


2008©ExactAntigen home | browse | about